Atai Beckley Inc.

Healthcare

NASDAQ:ATAI · NASDAQ Global Market

Market Cap $1.49B Beta 1.60 P/E (TTM) -1.4

$4.06 -1.35%

-$0.06 today

52W Low $2.00High $6.75

Vol 6.56M · Avg 5.68M

EPS (TTM) -$2.93Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+100.99%

Period High

$6.45

Period Low

$2.02

Latest

$4.06

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Dianthus Therapeutics, Inc.

NASDAQ:DNTH

$3.36B

Relay Therapeutics, Inc.

NASDAQ:RLAY

$2.79B

Enliven Therapeutics, Inc.

NASDAQ:ELVN

$2.75B

Syndax Pharmaceuticals, Inc.

NASDAQ:SNDX

$1.69B

Inhibrx Biosciences, Inc.

NASDAQ:INBX

$1.34B

Immatics N.V.

NASDAQ:IMTX

$1.30B

Amylyx Pharmaceuticals, Inc.

NASDAQ:AMLX

$1.28B

Nektar Therapeutics

NASDAQ:NKTR

$1.17B

ORIC Pharmaceuticals, Inc.

NASDAQ:ORIC

$884.39M

Sana Biotechnology, Inc.

NASDAQ:SANA

$850.26M

What is the latest ATAI filing?

The latest filing shown is 144 dated Mar 20, 2026.

How many recent filings does ATAI have?

Intrinsic Alpha currently shows 20 recent filings for ATAI.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.